Growth Hormone-Releasing Hormone (CJC-1295)

Mechanism of Action: A synthetic 29-amino acid peptide analog of Growth Hormone-Releasing Hormone (GHRH). It binds directly to GHRH receptors on pituitary somatotropes to stimulate the endogenous synthesis and secretion of Growth Hormone (GH).

Sustained GH Elevation:

• Extended Half-Life: Modifies normal GHRH structure to resist rapid enzymatic degradation in the bloodstream.

• Pulsatile GH Release: Maintains natural, physiological GH release pulses rather than causing continuous unnatural spikes, avoiding receptor desensitization.

• Systemic Stability: Sustains elevated baseline levels of both GH and Insulin-like Growth Factor 1 (IGF-1) in blood plasma over an extended period.

Muscle Growth & Tissue Repair:

• Protein Synthesis: Upregulates nitrogen retention and amino acid uptake within skeletal muscle tissue to accelerate hypertrophy.

• Micro-Tear Recovery: Speeds up the repair of damaged muscle fibers, tendons, and connective tissue following strenuous physical exercise or mechanical stress.

• Hyperplasia Support: Works synergistically with elevated local IGF-1 to support satellite cell activation and muscle cell proliferation.

Fat Loss & Metabolic Rate:

• Lipolysis Activation: Directly stimulates beta-oxidation, breaking down stored triglycerides into free fatty acids to be used as primary energy.

• Visceral & Subcutaneous Fat Target: Drives targeted reduction of both subcutaneous and deep visceral adipose tissue.

• Improved Body Composition: Promotes an optimal lean-to-fat mass ratio without inducing muscle catabolism during calorie deficits.